Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:FIGSNASDAQ:KRUSNASDAQ:LOGCNYSE:MYTE On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeFIGSFIGS$4.40-2.8%$4.34$3.57▼$7.06$715.22M1.22.76 million shs1.22 million shsKRUSKura Sushi USA$62.98-0.6%$57.45$40.03▼$110.66$765.59M1.55217,079 shs176,882 shsLOGCLogicBio Therapeutics$7.85+1.6%$2.06$0.26▼$3.77$206.30M2.06168,718 shs227,412 shsMYTEMYT Netherlands Parent B.V.$9.01-2.9%$7.96$3.22▼$12.50$772.15M1.08202,415 shs112,266 shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceFIGSFIGS0.00%-5.99%+7.33%-19.73%-18.99%KRUSKura Sushi USA0.00%-6.89%+3.14%-9.84%-35.07%LOGCLogicBio Therapeutics+1.55%+0.64%+12.46%+4.11%+49.52%MYTEMYT Netherlands Parent B.V.-2.91%-5.56%+6.25%-16.04%+78.77%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationFIGSFIGS1.3102 of 5 stars1.03.00.00.00.64.21.9KRUSKura Sushi USA2.4053 of 5 stars3.31.00.00.02.41.71.9LOGCLogicBio Therapeutics0.805 of 5 stars0.02.00.04.70.60.80.6MYTEMYT Netherlands Parent B.V.2.0265 of 5 stars3.53.00.00.02.60.00.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceFIGSFIGS 2.00Hold$4.502.39% UpsideKRUSKura Sushi USA 2.55Moderate Buy$77.2022.58% UpsideLOGCLogicBio Therapeutics 0.00N/AN/AN/AMYTEMYT Netherlands Parent B.V. 3.00Buy$14.0055.38% UpsideCurrent Analyst Ratings BreakdownLatest LOGC, MYTE, KRUS, and FIGS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/13/2025FIGSFIGSBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingPositive ➝ Positive5/13/2025FIGSFIGSBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$4.00 ➝ $5.005/13/2025FIGSFIGSTelsey Advisory GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Perform ➝ Market Perform$5.00 ➝ $5.005/5/2025FIGSFIGSTelsey Advisory GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetMarket Perform ➝ Market Perform$7.00 ➝ $5.004/22/2025FIGSFIGSThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetSell ➝ Sell$4.25 ➝ $3.754/17/2025FIGSFIGSMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$4.75 ➝ $4.254/10/2025KRUSKura Sushi USACitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$71.00 ➝ $47.004/9/2025KRUSKura Sushi USAWilliam BlairSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform4/9/2025KRUSKura Sushi USALake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$103.00 ➝ $62.004/9/2025KRUSKura Sushi USABarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$75.00 ➝ $52.004/4/2025KRUSKura Sushi USATD SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold ➝ Hold$72.00 ➝ $72.00(Data available from 5/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookFIGSFIGS$561.17M1.27$0.12 per share36.36$2.22 per share1.98KRUSKura Sushi USA$258.44M2.94$0.87 per share72.15$14.45 per share4.36LOGCLogicBio Therapeutics$287M0.72N/AN/A$8.96 per share0.88MYTEMYT Netherlands Parent B.V.$881.44M0.88N/AN/A$5.19 per share1.74Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateFIGSFIGS$22.64M$0.0173.2562.7931.621.97%2.76%2.11%N/AKRUSKura Sushi USA-$8.80M-$0.90N/A143.14N/A-3.08%-0.50%-0.26%7/8/2025 (Estimated)LOGCLogicBio Therapeutics-$317M-$5.79N/A∞N/A-141.03%-81.98%-52.13%N/AMYTEMYT Netherlands Parent B.V.-$26.95M-$0.43N/A112.63N/A-3.98%-5.88%-3.63%N/ALatest LOGC, MYTE, KRUS, and FIGS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/9/2025Q1 2025LOGCLogicBio TherapeuticsN/A-$0.27N/A-$0.27N/AN/A4/8/2025Q2 2025KRUSKura Sushi USA-$0.08-$0.14-$0.06-$0.31$66.30 million$64.89 million3/12/2025Q4 2024LOGCLogicBio TherapeuticsN/A-$0.08N/A-$0.08N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthFIGSFIGSN/AN/AN/AN/AN/AKRUSKura Sushi USAN/AN/AN/AN/AN/ALOGCLogicBio TherapeuticsN/AN/AN/AN/AN/AMYTEMYT Netherlands Parent B.V.N/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioFIGSFIGSN/A4.583.28KRUSKura Sushi USAN/A3.473.40LOGCLogicBio TherapeuticsN/A31.6031.60MYTEMYT Netherlands Parent B.V.0.091.780.22Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipFIGSFIGS92.21%KRUSKura Sushi USA65.49%LOGCLogicBio Therapeutics46.05%MYTEMYT Netherlands Parent B.V.10.07%Insider OwnershipCompanyInsider OwnershipFIGSFIGS22.30%KRUSKura Sushi USA2.30%LOGCLogicBio Therapeutics8.10%MYTEMYT Netherlands Parent B.V.1.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableFIGSFIGS310162.55 million131.94 millionOptionableKRUSKura Sushi USA2,10012.09 million11.79 millionNot OptionableLOGCLogicBio Therapeutics6226.28 million24.16 millionOptionableMYTEMYT Netherlands Parent B.V.1,24085.70 million83.65 millionOptionableLOGC, MYTE, KRUS, and FIGS HeadlinesRecent News About These Companies1,676,878 Shares in MYT Netherlands Parent B.V. (NYSE:MYTE) Bought by Woodson Capital Management LPMay 22 at 6:09 AM | marketbeat.comCubist Systematic Strategies LLC Acquires Shares of 28,692 MYT Netherlands Parent B.V. (NYSE:MYTE)May 21, 2025 | marketbeat.comMYT Netherlands Parent B.V. (MYTE) Expected to Announce Earnings on WednesdayMay 9, 2025 | marketbeat.comMYT Netherlands Parent B.V. (NYSE:MYTE) Shares Bought by CastleKnight Management LPMay 8, 2025 | marketbeat.comBoothbay Fund Management LLC Buys Shares of 102,627 MYT Netherlands Parent B.V. (NYSE:MYTE)May 2, 2025 | marketbeat.comMYT Netherlands Parent B.V. (NYSE:MYTE) Trading Down 3.5% - What's Next?April 30, 2025 | marketbeat.comWhy MYT Netherlands Parent B.V.’s (MYTE) Stock Is Down 5.04%April 29, 2025 | aaii.comWalleye Capital LLC Makes New Investment in MYT Netherlands Parent B.V. (NYSE:MYTE)April 28, 2025 | marketbeat.comInvesco Ltd. Trims Stock Holdings in MYT Netherlands Parent B.V. (NYSE:MYTE)April 28, 2025 | marketbeat.comMYT Netherlands Parent B.V. (“Mytheresa”) and Richemont Announce the Successful Completion of Mytheresa’s Acquisition of YOOX NET-A-PORTER (“YNAP”)April 27, 2025 | businesswire.comApril 24, 2025 | gurufocus.comMYT Netherlands Parent B.V. ("Mytheresa") and Richemont announce the successful completion of Mytheresa's acquisition of YOOX NET-A-PORTER ("YNAP")April 24, 2025 | globenewswire.comMYT Netherlands Parent B.V. (“Mytheresa”) and Richemont Announce the Successful Completion of Mytheresa's Acquisition of YOOX NET-A-PORTER (“YNAP”)April 24, 2025 | businesswire.comMytheresa Announces Third Quarter of Fiscal Year 2025 Earnings Release and Conference Call; ...April 23, 2025 | gurufocus.comMYT Netherlands Parent B.V. to be Renamed LuxExperience B.V.April 22, 2025 | finance.yahoo.comMYT Netherlands Parent B.V. to be Renamed LuxExperience B.V. | MYTE Stock NewsApril 21, 2025 | gurufocus.comMYT Netherlands Parent B.V. Announces New Senior Leadership Team Following the Acquisition of YOOX NET-A-PORTERApril 11, 2025 | businesswire.comMYT Netherlands Parent B.V. (“Mytheresa”) receives final regulatory clearance to acquire YOOX NET-A-PORTER (“YNAP”) from Richemont, with closing planned for 23 April 2025April 11, 2025 | globenewswire.comStrength Seen in MYT Netherlands Parent (MYTE): Can Its 7.5% Jump Turn into More Strength?April 9, 2025 | zacks.comStrength Seen in MYT Netherlands Parent (MYTE): Can Its 7.5% Jump Turn into More Strength?April 9, 2025 | zacks.comIs MYT Netherlands Parent (MYTE) the Best German Stock to Buy According to Hedge Funds?April 3, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeLOGC, MYTE, KRUS, and FIGS Company DescriptionsFIGS NYSE:FIGS$4.39 -0.13 (-2.77%) Closing price 05/23/2025 03:59 PM EasternExtended Trading$4.38 -0.02 (-0.46%) As of 05/23/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.FIGS, Inc. operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. It designs and sells healthcare apparel and scrubwear and non-scrubwear offerings, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel. It also offers sports bras, performance leggings, tops, super-soft pima cotton tops, vests, fleeces, and jackets; necessities, scrub caps, lanyards, badge reels, tote bags, baseball caps, and beanies. The company markets and sells its products to healthcare professionals through its direct-to-consumer digital platform comprising website, mobile app, and B2B business, as well as retail store. FIGS, Inc. was founded in 2013 and is headquartered in Santa Monica, California. FIGS, Inc.Kura Sushi USA NASDAQ:KRUS$62.98 -0.37 (-0.58%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$62.07 -0.91 (-1.45%) As of 05/23/2025 05:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Kura Sushi USA, Inc. operates technology-enabled Japanese restaurants in the United States. The company was formerly known as Kula Sushi USA, Inc. and changed its name to Kura Sushi USA, Inc. in October 2017. The company was founded in 2008 and is headquartered in Irvine, California. Kura Sushi USA, Inc. is a subsidiary of Kura Sushi, Inc.LogicBio Therapeutics NASDAQ:LOGCLogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is an adeno-associated virus, which is designed to optimize gene delivery for treatments in a range of indications and tissues. Its lead product candidate is LB-001 that is in Phase I/II clinical trials for the treatment of methylmalonic acidemia. The company has a collaboration with Children's Medical Research Institute to develop next-generation capsids for gene therapy and gene editing applications in the liver, as well as additional tissues; and a collaboration agreement with Takeda Pharmaceutical Company Limited to develop LB-301, an investigational therapy for the treatment of Crigler-Najjar syndrome. The company also has a research collaboration, license, and option agreement with CANbridge Care Pharma Hong Kong Limited; and collaboration agreement with Daiichi Sankyo Company. The company was incorporated in 2014 and is headquartered in Lexington, Massachusetts.MYT Netherlands Parent B.V. NYSE:MYTE$9.01 -0.27 (-2.91%) As of 05/23/2025MYT Netherlands Parent B.V., through its subsidiary, Mytheresa Group GmbH, operates a luxury e-commerce platform for fashion consumers in Germany, the United States, rest of Europe, and internationally. It offers womenswear, menswear, kids wear, and lifestyle products. The company sells clothes, bags, shoes, accessories, and fine jewelry through online and retail stores. It serves high-income luxury consumers. The company was founded in 1987 and is based in Munich, Germany. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/19 - 05/23 Trade Desk Silences Critics; Recovery Looks Poised to Continue Booz Allen Hamilton Earnings: 3 Bullish Signals for BAH Stock Turbulence for Joby Shares: What's Behind the Recent Dip? Pfizer's 7.5% Dividend: Income Haven or House of Cards? TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain These ETFs Provide Easy Exposure to Growing International Markets Advance Auto Parts Jumps on Surprise Earnings Beat Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
